Understanding the new Psoriatic Arthritis Treatment Guidelines
NPF and the American College of Rheumatology have released treatment guidelines for psoriatic arthritis (PsA). The guidelines are significant because they provide health care professionals with the most accurate, up-to-date, evidence-based standards for treating PsA patients.
The guidelines could have a significant impact on the way active PsA is treated, especially for those people with PsA:
- Who have never been treated for PsA
- Who have tried and failed different treatments
The top three recommendations in the guidelines:
Follow a Treat to Target approach
PsA can cause irreversible joint damage. This damage could be delayed or even avoided – and pain, joint function and quality of life could be improved by using a targeted treatment approach.
Employ tumor necrosis factor inhibitor (TNFi) biologics as first-line therapy
By making the case for using TNFi biologics first, the guidelines help health care providers and patients choose the optimal therapy.
Smoking has been shown to reduce the efficacy of biologics and has long been linked to mortality, cancer, heart disease and lung disease. If you smoke, now is a good time to try quitting. Talk to your doctor if you need help.
Follow the links below to learn more.